Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.05 USD | -2.27% | -5.43% | -6.70% |
May. 09 | Enfusion Shares Fall Despite Higher Q1 Results | MT |
May. 09 | Transcript : Enfusion, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 205M | Sales 2025 * | 243M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2024 * | 12M | Net income 2025 * | 27M | EV / Sales 2024 * | 3.75 x |
Net cash position 2024 * | 54.12M | Net cash position 2025 * | 91.23M | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
119
x | P/E ratio 2025 * |
53.8
x | Employees | 1,102 |
Yield 2024 * |
0.11% | Yield 2025 * |
-
| Free-Float | 39.63% |
Latest transcript on Enfusion, Inc.
1 day | -2.27% | ||
1 week | -5.43% | ||
Current month | -2.79% | ||
1 month | -5.33% | ||
3 months | +8.38% | ||
6 months | -4.03% | ||
Current year | -6.70% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 63 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.05 | -2.27% | 504,031 |
24-05-09 | 9.26 | -5.22% | 589,326 |
24-05-08 | 9.77 | +0.41% | 280,145 |
24-05-07 | 9.73 | -0.51% | 259,873 |
24-05-06 | 9.78 | +2.19% | 421,891 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.70% | 822M | |
+10.29% | 3,082B | |
+8.12% | 84.92B | |
+5.55% | 78.23B | |
-13.73% | 54.06B | |
-24.43% | 46.79B | |
+19.98% | 45.87B | |
+21.26% | 42.65B | |
+60.27% | 37.28B | |
-9.36% | 24.89B |
- Stock Market
- Equities
- ENFN Stock